Infosys complaint in US court claims S Ravi Kumar deliberately delayed by 18 months the rollout Helix that rivals Cognizant's healthcare solution as he was in talks to join as CEO of the Nasdaq-listed ...

In hypercompetitive times when companies have to fight for every percentage point of margin, the days of senior leaders ...

In today’s newsletter, we take a look at the real money gaming industry, which got a small breather on Friday when the ...

Infosys has escalated its legal battle against Cognizant by filing a counterclaim accusing Cognizant and CEO Ravi Kumar of anti-competitive tactics to hinder its Helix healthcare platform. Infosys ...

BENGALURU: Infosys filed a counterclaim against Cognizant in a US court, alleging that its rival Cognizant and its CEO, Ravi Kumar, engaged in anticompetitive practices to stifle competition and ...

Infosys claims that Kumar, a former senior executive at the company, obstructed Helix’s development by withholding resources ...

Infosys, which filed this suit in the Northern District of Texas, has requested a jury trial and demanded triple the damages it claims to have suffered ...

On the counterclaim filed by Infosys in the TriZetto trade secrets case, Kumar says he is protecting the intellectual ...

India’s second-largest software exporter Infosys has filed a counterclaim against NASDAQ-listed Cognizant on January 10 in a US Court, alleging that the company and its CEO, Ravi Kumar ...

Infosys filed a counter lawsuit against Cognizant accusing it of using unfair tactics and trade secret misuse to hinder its healthcare platform, Infosys Helix. Ravi Kumar S, a former Infosys executive ...

Infosys has escalated its legal battle against Cognizant by filing a counterclaim accusing Cognizant and CEO Ravi Kumar of anti-competitive tactics to hinder its Helix healthcare platform.